Venture capital biotech player Foresite Capital has locked down $900 million for its latest vehicle.

Foresite Capital Fund VI marks the largest single-fund raise for the multi-stage healthcare and life sciences investment firm. It comes as top biotech startups have shaken off high interest rates to maintain attractive valuations-with eyes on a crop of promising I